Is it necessary to continue taking Obeticholic acid without interruption?
Obeticholic acid is a farnesoid The drug helps improve liver function indicators by regulating bile acid metabolism and reducing liver inflammation. Since its mechanism of action targets chronic pathological processes, treatment usually requires long-term or even lifelong maintenance to continuously control disease progression and delay liver fibrosis and liver failure.
Obeticholic acid is not a quick-acting drug, and its therapeutic effect is mainly reflected in long-term improvement of liver metabolic status and inflammatory response. Once medication is discontinued, bile acid metabolism may return to abnormality, and liver inflammation and fibrosis may be accelerated, leading to disease rebound or even worsening. Therefore, clinically, it is usually recommended that patients adhere to long-term medication unless serious adverse reactions occur or the doctor clearly instructs to discontinue medication.
If the patient needs to temporarily stop taking the medicine due to side effects or other reasons, he should do so under the guidance of a professional doctor and avoid stopping the medicine on his own. Abrupt discontinuation of obeticholic acid may result in loss of disease control and even worsening of liver function indicators. If any discomfort occurs during medication, you should promptly seek medical evaluation, adjust the dosage or take other supportive treatment instead of interrupting without authorization.
Overall, as obeticholic acid is an important treatment for chronic liver disease, continuous medication is usually required to maintain the efficacy after taking it. Patients should maintain close communication with their doctors, regularly monitor changes in liver function and condition, and reasonably assess drug tolerance. Adhering to standardized medication not only helps to delay the progression of the disease, but also significantly improves the quality of life and avoids health risks caused by interruption of treatment.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)